Restricted Research - Award List, Note/Discussion Page

Fiscal Year: 2018

1723  University of Houston  (75541)

Principal Investigator: Rajender R Aparasu

Total Amount of Contract, Award, or Gift (Annual before 2011): $ 384,242

Exceeds $250,000 (Is it flagged?): Yes

Start and End Dates: 7/15/17 - 6/30/19

Restricted Research: YES

Academic Discipline: PHAR HEALTH OUTCOMES & POLICY

Department, Center, School, or Institute: DEAN, PHARMACY

Title of Contract, Award, or Gift: SAFETY PROFILE OF ANTIMUSCARINICS IN ELDERLY DEMENTIA PATIENTS

Name of Granting or Contracting Agency/Entity: National Institute on Aging
CFDA Link: HHS
93.866

Program Title: none
CFDA Linked: Aging Research

Note:

1.1.1 - The goal of this research is to evaluate safety profile of antimuscarinics in patients with dementia and OAB. Understanding the impact of receptor selectivity and their association with adverse health outcomes is critical for providers to enable them to make informed decisions regarding the use of antimuscarinics for the treatment of OAB among the dementia patients.

Discussion: No discussion notes

 

Close Window